Page last updated: 2024-09-02

aluminum phthalocyanine and etoposide

aluminum phthalocyanine has been researched along with etoposide in 1 studies

Compound Research Comparison

Studies
(aluminum phthalocyanine)
Trials
(aluminum phthalocyanine)
Recent Studies (post-2010)
(aluminum phthalocyanine)
Studies
(etoposide)
Trials
(etoposide)
Recent Studies (post-2010) (etoposide)
12834018,3063,6934,900

Protein Interaction Comparison

ProteinTaxonomyaluminum phthalocyanine (IC50)etoposide (IC50)
nuclear receptor coactivator 1 isoform 1 [Homo sapiens]Homo sapiens (human)1.153
nuclear receptor coactivator 3 isoform aHomo sapiens (human)1.4284
Polyunsaturated fatty acid lipoxygenase ALOX15Oryctolagus cuniculus (rabbit)3.187
Caspase-3Homo sapiens (human)1
DNA topoisomerase 2-betaHomo sapiens (human)0.4299
Solute carrier organic anion transporter family member 1B3Homo sapiens (human)4.18

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brasseur, N; Gantchev, TG; van Lier, JE1

Other Studies

1 other study(ies) available for aluminum phthalocyanine and etoposide

ArticleYear
Combination toxicity of etoposide (VP-16) and photosensitisation with a water-soluble aluminium phthalocyanine in K562 human leukaemic cells.
    British journal of cancer, 1996, Volume: 74, Issue:10

    Topics: Antineoplastic Agents, Phytogenic; Cell Cycle; Cell Division; Combined Modality Therapy; DNA, Neoplasm; Drug Interactions; Etoposide; Humans; Indoles; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Nucleosomes; Organometallic Compounds; Photochemotherapy; Photosensitizing Agents; Tumor Cells, Cultured

1996